Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 31, 2025Bioinformation

Current trends on immunotherapy for oncology

View Full Paper
Ask AI
Bookmark
Share

Authors

NCNGopi ChanderAPA PrashannalakshmiPRPhanish Chandra Ravi

Discussion

Loading...

Member takes

Overview

Review demonstrates the impact of immune checkpoint inhibitors and CAR T-cell therapies on cancer treatment, highlighting emerging strategies.

Key Points

  • Immunotherapy leads to durable responses, revolutionizing oncological treatment across many malignancies.
  • Immune checkpoint inhibitors targeting PD-1, PD-L1, and CTLA-4 have become the standard of care for numerous solid tumors.
  • Research into novel checkpoint targets and personalized immunotherapy approaches aims to improve treatment efficacy and address resistance.
  • Challenges such as treatment costs and immune-related toxicities underscore the need for biomarker development and combination therapies.

Cite This Study

Chander et al. (2025) studied this question.

synapsesocial.com/papers/68af2979cf1dd9ea359e328ehttps://doi.org/10.6026/973206300211880
View Full Paper
Ask AI
Bookmark
Share